"ID","FLDNAME","TBLNAME","CRFNAME","QUESTION","TEXT","STATUS","DEPRULE","TYPE","LENGTH","DECIML","RANGEVAL","RANGESQL","RANGEPRL","UNITS","CODE","NOTES","OBJID","COLID","RANGEJSCPT","NAVJSCPT","FTYPE","TAB","DE","MC","VISIBLE","LOGVISIBLE","MTBLNAME","SUBTBLNAME","POPJSCPT","GRID","DEF","update_stamp"
"","RID","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","","","","N","","","","","","","","","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","VISCODE","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","","","","T","","","","","","","","","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","EXAMDATE","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","","","","D","","","","","","","","","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","IMAGEUID","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","","","","N","","","","","","","","","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","HIPPL01","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from Hippocampus_L","","","N","8","6",">0","","","Normalized Counts","NA","(1). Included baseline FDG-PET scans after excluding scans with QA/acquisioon concerns, ANOVA  design (factors such as age, gender, apoe4 etc. are not considered in the analysis).   (2) local maxima extracted by examining lower CMRgl in AD cases than in controls (but with MCI data included in  the table). (3) (internal note) analysis on linux:   /san2/analysis/ADNI/quals/analysis/bsln_072307/All_minus_HRRTandBiograph. (4) SPM analyses were performed by ADNI Analysis Team Members: Kewei Chen, Ph.D., Eric M. Reiman, M.D. Gene E. Alexander, Ph.D.  with in mind issues such as the correction of multiple comparisons. (5) data subject to change due to addtion/change of subjects, time points and/or analysis type (6), some brain regions, reported in AD neuroimaging literature, are included in the table w/o numeric data. (7), the field name consists of two parts: part 1 (the character string, maximum of 8 characters) is the brain region, and part 2 (the two digits at the very end) are index indicating analysis types.  Variable suffix 01 corresponds to baseline AD glucose hypometabolsim compared to Normal Controls","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","FRTSUPL01","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from Frontal_sup_L","","","N","8","6",">0","","","Normalized Counts","NA","Same as for HippL01","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","FRTMIDL01","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from Frontal_mid_L","","","N","8","6",">0","","","Normalized Counts","NA","Same as for HippL01","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","PARAHIPL01","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from ParaHippocampal_L","","","N","8","6",">0","","","Normalized Counts","NA","Same as for HippL01","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","FUSFRML01","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from Fusiform_L","","","N","8","6",">0","","","Normalized Counts","NA","Same as for HippL01","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","OCCMIDL01","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from Occipital_mid_L","","","N","8","6",">0","","","Normalized Counts","NA","Same as for HippL01","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","ANGULL01","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from Angular_L","","","N","8","6",">0","","","Normalized Counts","NA","Same as for HippL01","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","PARIINFL01","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from Parietal_Inf_L","","","N","8","6",">0","","","Normalized Counts","NA","Same as for HippL01","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","SUPMRGL01","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from SupraMarginal_L","","","N","8","6",">0","","","Normalized Counts","NA","Same as for HippL01","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","TMPMIDL01","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from Temporal _mid_L","","","N","8","6",">0","","","Normalized Counts","NA","Same as for HippL01","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","PRECUNL01","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from Precuneus_L","","","N","8","6",">0","","","Normalized Counts","NA","Same as for HippL01","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","CINGPSTL01","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from Cingulum_Post_L","","","N","8","6",">0","","","Normalized Counts","NA","Same as for HippL01","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","PARAHIPR01","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from ParaHippocampal_R","","","N","8","6",">0","","","Normalized Counts","NA","Same as for HippL01","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","FRTSUPR01","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from Frontal_Sup_R","","","N","8","6",">0","","","Normalized Counts","NA","Same as for HippL01","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","OCCMIDR01","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from Occipital_mid_R","","","N","8","6",">0","","","Normalized Counts","NA","Same as for HippL01","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","FUSFRMR01","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from Fusiform_R","","","N","8","6",">0","","","Normalized Counts","NA","Same as for HippL01","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","FRTMIDR01","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from Frontal_mid_R","","","N","8","6",">0","","","Normalized Counts","NA","Same as for HippL01","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","ANGULR01","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from Angular_R","","","N","8","6",">0","","","Normalized Counts","NA","Same as for HippL01","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","PARIINFR01","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from Parietal_Inf_R","","","N","8","6",">0","","","Normalized Counts","NA","Same as for HippL01","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","TMPMIDR01","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from Temporal_mid_R","","","N","8","6",">0","","","Normalized Counts","NA","Same as for HippL01","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","SUPMRGR01","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from SupraMarginal_R","","","N","8","6",">0","","","Normalized Counts","NA","Same as for HippL01","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","PRCUNSR01","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from Prcuneus_R","","","N","8","6",">0","","","Normalized Counts","NA","Same as for HippL01","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","HIPPR01","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from Hippocampus_R","","","N","8","6",">0","","","Normalized Counts","NA","Same as for HippL01","","","","","","","","Not done","","","","","","","","2011-04-20 12:41:43.0"
"","LINGUALL01","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from Lingual_L","","","N","8","6",">0","","","Normalized Counts","NA","Same as for HippL01","","","","","","","","Not done","","","","","","","","2011-04-20 12:41:43.0"
"","LINGUALR01","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from Lingual_R","","","N","8","6",">0","","","Normalized Counts","NA","Same as for HippL01","","","","","","","","Not done","","","","","","","","2011-04-20 12:41:43.0"
"","CINGPSTR01","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from Cingulum_Post_R","","","N","8","6",">0","","","Normalized Counts","NA","Same as for HippL01","","","","","","","","Not done","","","","","","","","2011-04-20 12:41:43.0"
"","FRTINFL01","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from Frontal_Inf_L","","","N","8","6",">0","","","Normalized Counts","NA","Same as for HippL01","","","","","","","","Not done","","","","","","","","2011-04-20 12:41:43.0"
"","FRTINFR01","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from Frontal_Inf_R","","","N","8","6",">0","","","Normalized Counts","NA","Same as for HippL01","","","","","","","","Not done","","","","","","","","2011-04-20 12:41:43.0"
"","PARISUPL01","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from Parietal_Sup_L","","","N","8","6",">0","","","Normalized Counts","NA","Same as for HippL01","","","","","","","","Not done","","","","","","","","2011-04-20 12:41:43.0"
"","PARISUPR01","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from Parietal_Sup_R","","","N","8","6",">0","","","Normalized Counts","NA","Same as for HippL01","","","","","","","","Not done","","","","","","","","2011-04-20 12:41:43.0"
"","INSULAL01","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from Insula_L","","","N","8","6",">0","","","Normalized Counts","NA","Same as for HippL01","","","","","","","","Not done","","","","","","","","2011-04-20 12:41:43.0"
"","INSULAR01","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from Insula_R","","","N","8","6",">0","","","Normalized Counts","NA","Same as for HippL01","","","","","","","","Not done","","","","","","","","2011-04-20 12:41:43.0"
"","CINGANTL01","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from Cingulum_Ant_L","","","N","8","6",">0","","","Normalized Counts","NA","Same as for HippL01","","","","","","","","Not done","","","","","","","","2011-04-20 12:41:43.0"
"","CINGANTR01","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from Cingulum_Ant_R","","","N","8","6",">0","","","Normalized Counts","NA","Same as for HippL01","","","","","","","","Not done","","","","","","","","2011-04-20 12:41:43.0"
"","CINGMIDL01","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from Cingulum_Mid_L","","","N","8","6",">0","","","Normalized Counts","NA","Same as for HippL01","","","","","","","","Not done","","","","","","","","2011-04-20 12:41:43.0"
"","CINGMIDR01","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from Cingulum_Mid_R","","","N","8","6",">0","","","Normalized Counts","NA","Same as for HippL01","","","","","","","","Not done","","","","","","","","2011-04-20 12:41:43.0"
"","TMPSUPL01","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from Temporal _Sup_L","","","N","8","6",">0","","","Normalized Counts","NA","Same as for HippL01","","","","","","","","Not done","","","","","","","","2011-04-20 12:41:43.0"
"","TMPSUPR01","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from Temporal _Sup_R","","","N","8","6",">0","","","Normalized Counts","NA","Same as for HippL01","","","","","","","","Not done","","","","","","","","2011-04-20 12:41:43.0"
"","TMPINFL01","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from Temporal_Inf_L","","","N","8","6",">0","","","Normalized Counts","NA","Same as for HippL01","","","","","","","","Not done","","","","","","","","2011-04-20 12:41:43.0"
"","TMPINFR01","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from Temporal_Inf_R","","","N","8","6",">0","","","Normalized Counts","NA","Same as for HippL01","","","","","","","","Not done","","","","","","","","2011-04-20 12:41:43.0"
"","FRTSUPL02","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from Frontal_Sup_L","","","N","8","6",">0","","","Normalized Counts","NA","(1). Included baseline FDG-PET scans after excluding scans with QA/acquisioon concerns, ANOVA  design (factors such as age, gender, apoe4 etc. are not considered in the analysis).                          (2) local maxima extracted by examining lower CMRgl in MCI cases than in controls (but with AD data included in the table). (3) (internal note) analysis on linux:  /san2/analysis/ADNI/quals/analysis/bsln_072307/All_minus_HRRTandBiograph. (4) SPM analyses were performed by ADNI Analysis Team Members: Kewei Chen, Ph.D., Eric M. Reiman, M.D. Gene E. Alexander, Ph.D.  with in mind issues such as the correction of multiple comparisons. (5) data subject to change due to addtion/change of subjects, time points and/or analysis type (6), some brain regions, reported in AD neuroimaging literature, are included in the table w/o numeric data. (7), the field name consists of two parts: part 1 (the character string, maximum of 8 characters) is the brain region, and part 2 (the two digits at the very end) are index indicating analysis types. Variable suffix 02 corresponds to baseline MCI CMRgl decline compared to Normal Controls ","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","FRTMIDL02","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from Frontal_Mid_L","","","N","8","6",">0","","","Normalized Counts","NA","Same as for FrtSupL02","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","CINGPSTL02","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from Cingulum_Post_L","","","N","8","6",">0","","","Normalized Counts","NA","Same as for FrtSupL02","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","CINGMIDL02","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from Cingulum_Mid_L","","","N","8","6",">0","","","Normalized Counts","NA","Same as for FrtSupL02","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","FRTSMEDL02","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from Frontal_Sup_Medial_L","","","N","8","6",">0","","","Normalized Counts","NA","Same as for FrtSupL02","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","FUSFRML02","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from Fusiform_L","","","N","8","6",">0","","","Normalized Counts","NA","Same as for FrtSupL02","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","TMPMIDL02","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from Temporal_Mid_L","","","N","8","6",">0","","","Normalized Counts","NA","Same as for FrtSupL02","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","OCCMIDL02","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from Occipital_Mid_L","","","N","8","6",">0","","","Normalized Counts","NA","Same as for FrtSupL02","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","TMPINFL02","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from Temporal_Inf_L","","","N","8","6",">0","","","Normalized Counts","NA","Same as for FrtSupL02","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","PRECUNL02","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from Precuneus_L","","","N","8","6",">0","","","Normalized Counts","NA","Same as for FrtSupL02","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","CINGANTL02","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from Cingulum_Ant_L","","","N","8","6",">0","","","Normalized Counts","NA","Same as for FrtSupL02","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","FRTMIDOR02","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from Frontal_Mid_Orb_R","","","N","8","6",">0","","","Normalized Counts","NA","Same as for FrtSupL02","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","FRTMIDR02","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from Frontal_Mid_R","","","N","8","6",">0","","","Normalized Counts","NA","Same as for FrtSupL02","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","FRTSUPR02","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from Frontal_Sup_R","","","N","8","6",">0","","","Normalized Counts","NA","Same as for FrtSupL02","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","ANGULR02","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from Angular_R","","","N","8","6",">0","","","Normalized Counts","NA","Same as for FrtSupL02","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","ANGULL02","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from Angular_L","","","N","8","6",">0","","","Normalized Counts","NA","Same as for FrtSupL02","","","","","","","","Not done","","","","","","","","2011-04-20 12:41:43.0"
"","PARIINFR02","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from Parietal_Inf_R","","","N","8","6",">0","","","Normalized Counts","NA","Same as for FrtSupL02","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","TMPMIDR02","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from Temporal_Mid_R","","","N","8","6",">0","","","Normalized Counts","NA","Same as for FrtSupL02","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","INSULAR02","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from Insula_R","","","N","8","6",">0","","","Normalized Counts","NA","Same as for FrtSupL02","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","TMPPOSR02","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from Temporal_Pole_Sup_R","","","N","8","6",">0","","","Normalized Counts","NA","Same as for FrtSupL02","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","CINGANTR02","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from Cingulum_Ant_R","","","N","8","6",">0","","","Normalized Counts","NA","Same as for FrtSupL02","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","CINGMIDR02","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from Cingulum_Mid_R","","","N","8","6",">0","","","Normalized Counts","NA","Same as for FrtSupL02","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","PRECUNR02","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from Precuneus_R","","","N","8","6",">0","","","Normalized Counts","NA","Same as for FrtSupL02","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","RECTUSR02","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from Rectus_R","","","N","8","6",">0","","","Normalized Counts","NA","Same as for FrtSupL02","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","CINGPSTR02","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from Cingulum_Post_R","","","N","8","6",">0","","","Normalized Counts","NA","Same as for FrtSupL02","","","","","","","","Not done","","","","","","","","2011-04-20 12:41:43.0"
"","PARIINFL02","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from Parietal_Inf_L","","","N","8","6",">0","","","Normalized Counts","NA","Same as for FrtSupL02","","","","","","","","Not done","","","","","","","","2011-04-20 12:41:43.0"
"","INSULAL02","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from Insula_L","","","N","8","6",">0","","","Normalized Counts","NA","Same as for FrtSupL02","","","","","","","","Not done","","","","","","","","2011-04-20 12:41:43.0"
"","FRTINFL02","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from Frontal_Inf_L","","","N","8","6",">0","","","Normalized Counts","NA","Same as for FrtSupL02","","","","","","","","Not done","","","","","","","","2011-04-20 12:41:43.0"
"","FRTINFR02","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from Frontal_Inf_R","","","N","8","6",">0","","","Normalized Counts","NA","Same as for FrtSupL02","","","","","","","","Not done","","","","","","","","2011-04-20 12:41:43.0"
"","OCCMIDR02","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from Occipital_Mid_R","","","N","8","6",">0","","","Normalized Counts","NA","Same as for FrtSupL02","","","","","","","","Not done","","","","","","","","2011-04-20 12:41:43.0"
"","FRTMIDOL02","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from Frontal_Mid_Orb_Right","","","N","8","6",">0","","","Normalized Counts","NA","Same as for FrtSupL02","","","","","","","","Not done","","","","","","","","2011-04-20 12:41:43.0"
"","FRTSMEDR02","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from Frontal_Sup_Medial_R","","","N","8","6",">0","","","Normalized Counts","NA","Same as for FrtSupL02","","","","","","","","Not done","","","","","","","","2011-04-20 12:41:43.0"
"","FUSFMR02","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from Fusiform_R","","","N","8","6",">0","","","Normalized Counts","NA","Same as for FrtSupL02","","","","","","","","Not done","","","","","","","","2011-04-20 12:41:43.0"
"","RECTUSL02","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from Rectus_L","","","N","8","6",">0","","","Normalized Counts","NA","Same as for FrtSupL02","","","","","","","","Not done","","","","","","","","2011-04-20 12:41:43.0"
"","TMPPOSL02","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from Temporal_Pole_Sup_L","","","N","8","6",">0","","","Normalized Counts","NA","Same as for FrtSupL02","","","","","","","","Not done","","","","","","","","2011-04-20 12:41:43.0"
"","PARISUPL02","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from Parietal_Sup_L","","","N","8","6",">0","","","Normalized Counts","NA","Same as for FrtSupL02","","","","","","","","Not done","","","","","","","","2011-04-20 12:41:43.0"
"","PARISUPR02","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from Parietal_Sup_L","","","N","8","6",">0","","","Normalized Counts","NA","Same as for FrtSupL02","","","","","","","","Not done","","","","","","","","2011-04-20 12:41:43.0"
"","SUPMRGL02","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from SupraMarginal_L","","","N","8","6",">0","","","Normalized Counts","NA","Same as for FrtSupL02","","","","","","","","Not done","","","","","","","","2011-04-20 12:41:43.0"
"","SUPMRGR02","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from SupraMarginal_R","","","N","8","6",">0","","","Normalized Counts","NA","Same as for FrtSupL02","","","","","","","","Not done","","","","","","","","2011-04-20 12:41:43.0"
"","TMPINFR02","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Globally normalized CMRgl from Temporal_Inf_L","","","N","8","6",">0","","","Normalized Counts","NA","Same as for FrtSupL02","","","","","","","","Not done","","","","","","","","2011-04-20 12:41:43.0"
"","FRTMIDL03","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Frontal_Mid_L","","","N","8","6",">0","","","Normalized Counts","NA","(1). Included baseline/6 month FDG-PET scan pairs for AD patients after excluding scans with QA/acquisition concerns. Within group baseline vs. 6-month follow-up paired T-test design (factors such as age, gender, apoe4 etc. are not considered in the analysis).? (2) local maxima extracted by examining CMRgl decline in AD patients from baseline to followup. (3) (internal note) analysis on linux? /analysis/ADNI/quals/analysis/long_082007/ImgSubtract_bslm06_NPS/subgrp_AD (4) SPM analyses were performed by ADNI Analysis Team Members: Kewei Chen, Ph.D., Eric M. Reiman, M.D. Gene E. Alexander, Ph.D. with issues in mind such as the correction of multiple comparisons. (5), data subject to change due to addition/change of subjects, time points and/or analysis type. (6), some brain regions, reported in AD neuroimaging literature, are included in the table w/o numeric data. (7),  the field name consists of two parts: part 1 (the character string, maximum of 8 characters) is the brain region, and part 2 (the two digits at the very end) are index indicating analysis types. Variable suffix 03 corresponds to AD CMRgl decline over 6 month period","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","FRTMIDR03","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Frontal_Mid_R","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL03","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","FRTSUPL03","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Frontal_Sup_L","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL03","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","FRTSUPR03","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Frontal_Sup_R","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL03","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","FRTSMEDL03","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Frontal_Sup_Medial_L","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL03","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","FRTSMEDR03","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Frontal_Sup_Medial_R","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL03","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","TMPSUPL03","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Temporal_Sup_L","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL03","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","TMPSUPR03","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Temporal_Sup_R","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL03","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","TMPMIDL03","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Temporal_Mid_L","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL03","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","TMPMIDR03","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Temporal_Mid_R","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL03","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","TMPINFL03","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Temporal_Inf_L","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL03","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","TMPINFR03","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Temporal_Inf_R","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL03","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","FUSFRML03","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Fusiform_L","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL03","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","FUSFRMR03","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Fusiform_R","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL03","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","LINGUALL03","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Lingual_L","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL03","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","LINGUALR03","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Lingual_R","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL03","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","PARAHIPL03","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","ParaHippocampal_L","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL03","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","PARAHIPR03","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","ParaHippocampal_R","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL03","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","PARISUPL03","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Parietal_Sup_L","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL03","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","PARISUPR03","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Parietal_Sup_R","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL03","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","PARIINFL03","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Parietal_Inf_L","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL03","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","PARIINFR03","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Parietal_Inf_R","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL03","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","PRECUNL03","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Precuneus_L","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL03","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","PRECUNR03","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Precuneus_R","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL03","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","CINGANT03","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Cingulum_Ant","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL03","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","CINGMID03","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Cingulum_Mid","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL03","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","CINGPST03","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Cingulum_Post","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL03","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","ANGULR03","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Angular_R","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL03","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","OCCMIDL03","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Occipital_Mid_L","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL03","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","OCCMIDR03","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Occipital_Mid_R","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL03","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","OCCSUPL03","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Occipital_Sup_L","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL03","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","OCCSUPR03","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Occipital_Sup_R","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL03","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","OCCINFL03","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Occipital_Inf_L","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL03","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","OCCINFR03","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Occipital_Inf_R","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL03","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","THALAML03","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Thalamus_L","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL03","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","THALAMR03","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Thalamus_R","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL03","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","FRTMEDL03","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Frontal_Medial_Left","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL03","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","FRTMEDR03","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Frontal_Medial_Right","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL03","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","SUPMRGL03","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","SupraMarginal_L","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL03","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","SUPMRGR03","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","SupraMarginal_R","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL03","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","FRTMIDL04","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Frontal_Mid_L","","","N","8","6",">0","","","Normalized Counts","NA","(1). Included baseline/6 month FDG-PET scan pairs after excluding scans with QA/acquisition concerns, repeated ANOVA? design (factors such as age, gender, apoe4 etc. are not considered in the analysis).? (2) local maxima extracted by examining faster CMRgl decline in AD patients than in controls (MCI data included in  the table). (3) (internal note) analysis on linux? /analysis/ADNI/quals/analysis/long_082007/ANOVA_bslm06_NPS. (4) SPM analyses were performed by ADNI Analysis Team Members: Kewei Chen, Ph.D., Eric M. Reiman, M.D. Gene E. Alexander, Ph.D. with issues in mind such as the correction of multiple comparisons. (5), data subject to change due to addition/change of subjects, time points and/or analysis type. (6), some brain regions, reported in AD neuroimaging literature, are included in the table w/o numeric data.(7), the field name consists of two parts: part 1 (the character string, maximum of 8 characters) is the brain region, and part 2 (the two digits at the very end) are index indicating analysis types. Variable suffix 04 corresponds to AD CMRgl decline compared to that of normal controls over a 6 month period.","","","","","","","","To Be Done","","","","","","","","2011-04-20 12:41:43.0"
"","FRTMIDR04","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Frontal_Mid_R","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL04","","","","","","","","To Be Done","","","","","","","","2011-04-20 12:41:43.0"
"","FRTSUPL04","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Frontal_Sup_L","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL04","","","","","","","","To Be Done","","","","","","","","2011-04-20 12:41:43.0"
"","FRTSUPR04","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Frontal_Sup_R","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL04","","","","","","","","To Be Done","","","","","","","","2011-04-20 12:41:43.0"
"","FRTSMEDL04","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Frontal_Sup_Medial_L","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL04","","","","","","","","To Be Done","","","","","","","","2011-04-20 12:41:43.0"
"","FRTSMEDR04","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Frontal_Sup_Medial_R","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL04","","","","","","","","To Be Done","","","","","","","","2011-04-20 12:41:43.0"
"","TMPSUPL04","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Temporal_Sup_L","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL04","","","","","","","","To Be Done","","","","","","","","2011-04-20 12:41:43.0"
"","TMPSUPR04","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Temporal_Sup_R","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL04","","","","","","","","To Be Done","","","","","","","","2011-04-20 12:41:43.0"
"","TMPMIDL04","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Temporal_Mid_L","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL04","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","TMPMIDR04","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Temporal_Mid_R","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL04","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","TMPINFL04","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Temporal_Inf_L","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL04","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","TMPINFR04","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Temporal_Inf_R","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL04","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","FUSFRML04","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Fusiform_L","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL04","","","","","","","","To Be Done","","","","","","","","2011-04-20 12:41:43.0"
"","FUSFRMR04","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Fusiform_R","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL04","","","","","","","","To Be Done","","","","","","","","2011-04-20 12:41:43.0"
"","LINGUALL04","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Lingual_L","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL04","","","","","","","","To Be Done","","","","","","","","2011-04-20 12:41:43.0"
"","LINGUALR04","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Lingual_R","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL04","","","","","","","","To Be Done","","","","","","","","2011-04-20 12:41:43.0"
"","PARAHIPL04","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","ParaHippocampal_L","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL04","","","","","","","","To Be Done","","","","","","","","2011-04-20 12:41:43.0"
"","PARAHIPR04","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","ParaHippocampal_R","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL04","","","","","","","","To Be Done","","","","","","","","2011-04-20 12:41:43.0"
"","PARISUPL04","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Parietal_Sup_L","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL04","","","","","","","","To Be Done","","","","","","","","2011-04-20 12:41:43.0"
"","PARISUPR04","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Parietal_Sup_R","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL04","","","","","","","","To Be Done","","","","","","","","2011-04-20 12:41:43.0"
"","PARIINFL04","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Parietal_Inf_L","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL04","","","","","","","","To Be Done","","","","","","","","2011-04-20 12:41:43.0"
"","PARIINFR04","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Parietal_Inf_R","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL04","","","","","","","","To Be Done","","","","","","","","2011-04-20 12:41:43.0"
"","PRECUNL04","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Precuneus_L","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL04","","","","","","","","To Be Done","","","","","","","","2011-04-20 12:41:43.0"
"","PRECUNR04","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Precuneus_R","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL04","","","","","","","","To Be Done","","","","","","","","2011-04-20 12:41:43.0"
"","CINGANT04","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Cingulum_Ant","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL04","","","","","","","","To Be Done","","","","","","","","2011-04-20 12:41:43.0"
"","CINGMID04","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Cingulum_Mid","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL04","","","","","","","","To Be Done","","","","","","","","2011-04-20 12:41:43.0"
"","CINGPST04","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Cingulum_Post","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL04","","","","","","","","To Be Done","","","","","","","","2011-04-20 12:41:43.0"
"","OCCMIDL04","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Occipital_Mid_L","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL04","","","","","","","","To Be Done","","","","","","","","2011-04-20 12:41:43.0"
"","OCCMIDR04","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Occipital_Mid_R","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL04","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","OCCSUPL04","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Occipital_Sup_L","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL04","","","","","","","","To Be Done","","","","","","","","2011-04-20 12:41:43.0"
"","OCCSUPR04","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Occipital_Sup_R","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL04","","","","","","","","To Be Done","","","","","","","","2011-04-20 12:41:43.0"
"","OCCINFL04","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Occipital_Inf_L","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL04","","","","","","","","To Be Done","","","","","","","","2011-04-20 12:41:43.0"
"","OCCINFR04","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Occipital_Inf_R","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL04","","","","","","","","To Be Done","","","","","","","","2011-04-20 12:41:43.0"
"","THALAML04","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Thalamus_L","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL04","","","","","","","","To Be Done","","","","","","","","2011-04-20 12:41:43.0"
"","THALAMR04","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Thalamus_R","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL04","","","","","","","","To Be Done","","","","","","","","2011-04-20 12:41:43.0"
"","FRTMEDL04","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Frontal_Medial_Left","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL04","","","","","","","","To Be Done","","","","","","","","2011-04-20 12:41:43.0"
"","FRTMEDR04","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Frontal_Medial_Right","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL04","","","","","","","","To Be Done","","","","","","","","2011-04-20 12:41:43.0"
"","SUPMRGL04","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","SupraMarginal_L","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL04","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","SUPMRGR04","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","SupraMarginal_R","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL04","","","","","","","","To Be Done","","","","","","","","2011-04-20 12:41:43.0"
"","ANGULL04","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Angular_L","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL04","","","","","","","","To Be Done","","","","","","","","2011-04-20 12:41:43.0"
"","ANGULR04","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Angular_R","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL04","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","FRTMIDL05","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Frontal_Mid_L","","","N","8","6",">0","","","Normalized Counts","NA","(1). Included baseline/6 month FDG-PET scan pairs for 101 MCI patients after excluding scans with QA/acquisition concerns. Within group baseline vs. 6-month follow-up paired T-test design (factors such as age, gender, apoe4 etc. are not considered in the analysis).? (2) local maxima extracted by examining CMRgl decline in MCI patients from baseline to followup. (3) (internal note) analysis on linux? /analysis/ADNI/quals/analysis/long_082007/ImgSubtract_bslm06_NPS/subgrp_MC (4) SPM analyses were performed by ADNI Analysis Team Members: Kewei Chen, Ph.D., Eric M. Reiman, M.D. Gene E. Alexander, Ph.D. with issues in mind such as the correction of multiple comparisons. (5), data subject to change due to addition/change of subjects, time points and/or analysis type. (6), some brain regions, reported in AD/MCI neuroimaging literature, are included in the table w/o numeric data.(7), the field name consists of two parts: part 1 (the character string, maximum of 8 characters) is the brain region, and part 2 (the two digits at the very end) are index indicating analysis types. Variable Suffix 05 corresponds to MCI CMRgl decline over 6 month period","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","FRTMIDR05","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Frontal_Mid_R","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL05","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","FRTSUPL05","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Frontal_Sup_L","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL05","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","FRTSUPR05","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Frontal_Sup_R","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL05","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","FRTSMEDL05","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Frontal_Sup_Medial_L","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL05","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","FRTSMEDR05","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Frontal_Sup_Medial_R","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL05","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","TMPSUPL05","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Temporal_Sup_L","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL05","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","TMPSUPR05","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Temporal_Sup_R","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL05","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","TMPMIDL05","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Temporal_Mid_L","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL05","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","TMPMIDR05","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Temporal_Mid_R","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL05","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","TMPINFL05","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Temporal_Inf_L","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL05","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","TMPINFR05","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Temporal_Inf_R","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL05","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","FUSFRML05","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Fusiform_L","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL05","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","FUSFRMR05","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Fusiform_R","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL05","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","PARAHIPL05","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","ParaHippocampal_L","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL05","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","PARAHIPR05","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","ParaHippocampal_R","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL05","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","PARISUPL05","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Parietal_Sup_L","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL05","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","PARISUPR05","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Parietal_Sup_R","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL05","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","PARIINFL05","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Parietal_Inf_L","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL05","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","PARIINFR05","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Parietal_Inf_R","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL05","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","PRECUNL05","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Precuneus_L","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL05","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","PRECUNR05","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Precuneus_R","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL05","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","CINGANT05","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Cingulum_Ant","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL05","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","CINGMID05","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Cingulum_Mid","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL05","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","CINGPST05","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Cingulum_Post","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL05","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","OCCMIDL05","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Occipital_Mid_L","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL05","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","OCCMIDR05","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Occipital_Mid_R","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL05","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","OCCSUPL05","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Occipital_Sup_L","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL05","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","OCCSUPR05","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Occipital_Sup_R","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL05","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","OCCINFL05","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Occipital_Inf_L","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL05","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","OCCINFR05","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Occipital_Inf_R","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL05","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","THALAML05","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Thalamus_L","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL05","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","THALAMR05","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Thalamus_R","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL05","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","FRTMEDL05","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Frontal_Medial_Left","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL05","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","FRTMEDR05","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Frontal_Medial_Right","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL05","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","ANGULR05","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Angular_Right","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL05","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","ANGULL05","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Angular_Left","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL06","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","CALCARL05","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Calcarine_L","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL05","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","CALCARR05","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Calcarine_R","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL05","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","LINGUALL05","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Lingual_L","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL05","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","LINGUALR05","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Lingual_R","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL05","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","CEREB8L05","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Cerebelum_8_L","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL05","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","CEREB8R05","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Cerebelum_8_R","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL05","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","CERBCR2L05","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Cerebelum_Crus2_L","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL05","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","CERBCR2R05","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Cerebelum_Crus2_R","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL05","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","SUPMRGL05","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","SupraMarginal_L","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL05","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","SUPMRGR05","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","SupraMarginal_R","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL05","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","FRTMIDL06","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Frontal_Mid_L","","","N","8","6",">0","","","Normalized Counts","NA","(1). Included baseline/6 month FDG-PET scan pairs after excluding scans with QA/acquisition concerns, repeated ANOVA? design (factors such as age, gender, apoe4 etc. are not considered in the analysis).? (2) local maxima extracted by examining faster CMRgl decline in MCI patients than in controls (AD data included as well). (3) (internal note) analysis on linux? /analysis/ADNI/quals/analysis/long_082007/ANOVA_bslm06_NPS. (4) SPM analyses were performed by ADNI Analysis Team Members: Kewei Chen, Ph.D., Eric M. Reiman, M.D. Gene E. Alexander, Ph.D. with issues in mind such as the correction of multiple comparisons. (5), data subject to change due to addition/change of subjects, time points and/or analysis type. (6), some brain regions, reported in AD/MCI neuroimaging literature, are included in the table w/o numeric data. (7), the field name consists of two parts: part 1 (the character string, maximum of 8 characters) is the brain region, and part 2 (the two digits at the very end) are index indicating analysis types. Variable Suffix 06 corresponds to MCI CMRgl decline compared to that of normal controls over a 6 month period.","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","FRTMIDR06","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Frontal_Mid_R","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL06","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","FRTSUPL06","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Frontal_Sup_L","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL06","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","FRTSUPR06","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Frontal_Sup_R","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL06","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","FRTSMEDL06","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Frontal_Sup_Medial_L","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL06","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","FRTSMEDR06","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Frontal_Sup_Medial_R","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL06","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","TMPSUPL06","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Temporal_Sup_L","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL06","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","TMPSUPR06","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Temporal_Sup_R","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL06","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","TMPMIDL06","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Temporal_Mid_L","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL06","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","TMPMIDR06","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Temporal_Mid_R","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL06","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","TMPINFL06","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Temporal_Inf_L","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL06","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","TMPINFR06","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Temporal_Inf_R","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL06","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","FUSFRML06","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Fusiform_L","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL06","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","FUSFRMR06","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Fusiform_R","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL06","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","LINGUALL06","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Lingual_L","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL06","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","LINGUALR06","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Lingual_R","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL06","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","PARAHIPL06","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","ParaHippocampal_L","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL06","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","PARAHIPR06","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","ParaHippocampal_R","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL06","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","PARISUPL06","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Parietal_Sup_L","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL06","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","PARISUPR06","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Parietal_Sup_R","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL06","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","PARIINFL06","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Parietal_Inf_L","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL06","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","PARIINFR06","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Parietal_Inf_R","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL06","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","PRECUNL06","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Precuneus_L","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL06","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","PRECUNR06","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Precuneus_R","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL06","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","CINGANT06","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Cingulum_Ant","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL06","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","CINGMID06","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Cingulum_Mid","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL06","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","CINGPST06","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Cingulum_Post","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL06","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","OCCMIDL06","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Occipital_Mid_L","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL06","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","OCCMIDR06","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Occipital_Mid_R","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL06","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","OCCSUPL06","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Occipital_Sup_L","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL06","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","OCCSUPR06","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Occipital_Sup_R","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL06","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","OCCINFL06","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Occipital_Inf_L","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL06","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","OCCINFR06","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Occipital_Inf_R","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL06","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","THALAML06","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Thalamus_L","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL06","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","THALAMR06","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Thalamus_R","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL06","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","FRTMEDL06","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Frontal_Medial_Left","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL06","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","FRTMEDR06","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Frontal_Medial_Right","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL06","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","HIPPL06","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Hippocampus_L","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL06","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","HIPPR06","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Hippocampus_R","","","N","8","6",">0","","","Normalized Counts","NA","same as FrtMidL06","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","INDGLBNDX","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Individualized Global Index","","","N","9","6","[0,100]","","","Percentage","NA","(1). Included 298 baseline FDG-PET scans after excluding scans with QA/acquisioon concerns.  (2) each subject was compared, voxel-by-voxel, to our local database of normal subjects, the precentage of CMRgl reduction volume for each subject relative to the whole volume of the brain regions known to be affected by AD (Alexander et al AJP, 2002) globally or within the temporal cortex was calcuated. (3) (internal note) analysis on windows OS. (4) Analyses were performed by ADNI Analysis Team Members: Kewei Chen, Ph.D., Eric M. Reiman. (5) data subject to change/addition due to change of normal subjects (e.g., ADNI normal), addtional time points etc. (6), some brain regions, reported in AD neuroimaging literature, are included in the table w/o numeric data. (7), this global index is free of multiple comparison concern  ","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","INDTEPNDX","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Individualized Temporal index ","","","N","9","6","[0,100]","","","Percentage","NA","(1). Included 298 baseline FDG-PET scans after excluding scans with QA/acquisioon concerns.  (2) each subject was compared, voxel-by-voxel, to our local database of normal subjects, the precentage of CMRgl reduction volume for each subject relative to the whole volume of the brain regions known to be affected by AD (Alexander et al AJP, 2002) globally or within the temporal cortex was calcuated. (3) (internal note) analysis on windows OS. (4) Analyses were performed by ADNI Analysis Team Members: Kewei Chen, Ph.D., Eric M. Reiman. (5) data subject to change/addition due to change of normal subjects (e.g., ADNI normal), addtional time points etc. (6), some brain regions, reported in AD neuroimaging literature, are included in the table w/o numeric data. (7), this global index is free of multiple comparison concern  ","","","","","","","","To be done","","","","","","","","2011-04-20 12:41:43.0"
"","PRECUNL07","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Precuneus_L","","","N","8","6",">0","","","Normalized Counts","NA","(1). Included baseline/12 month FDG-PET scan pairs for AD patients. Within group baseline vs. 12-month follow-up paired T-test design (factors such as age, gender, apoe4 etc. are not considered in the analysis).? (2) local maxima extracted by examining CMRgl decline in AD patients from baseline to followup. (3) (internal note) analysis on linux? /analysis/ADNI/quals/analysis/Bmin12m_Feb08 (4) SPM analyses were performed by ADNI Analysis Team Members: Kewei Chen, Ph.D., Eric M. Reiman, M.D. Gene E. Alexander, Ph.D. with issues in mind such as the correction of multiple comparisons. (5), data subject to change due to addition/change of subjects, time points and/or analysis type. (6), some brain regions, reported in AD neuroimaging literature, are included in the table w/o numeric data. (7),  the field name consists of two parts: part 1 (the character string, maximum of 8 characters) is the brain region, and part 2 (the two digits at the very end) are index indicating analysis types. Variable Suffix 07 corresponds to AD CMRgl decline over 12 month period","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","CINGPST07","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Cingulum_Post","","","N","8","6",">0","","","Normalized Counts","NA","same as PrecunL07","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","PARIINFR07","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Parietal_Inf_R","","","N","8","6",">0","","","Normalized Counts","NA","same as PrecunL07","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","TMPMIDL07","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Temporal_Mid_L","","","N","8","6",">0","","","Normalized Counts","NA","same as PrecunL07","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","CUNEUSL08","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Cuneus_L","","","N","8","6",">0","","","Normalized Counts","NA","(1). Included baseline/12 month FDG-PET scan pairs, repeated ANOVA? design (factors such as age, gender, apoe4 etc. are not considered in the analysis).? (2) local maxima extracted by examining faster CMRgl decline in AD patients than in controls (MCI data included in  the table). (3) (internal note) analysis on linux/analysis/ADNI/quals/analysis/long_021308/ANOVA_bslm12. (4) SPM analyses were performed by ADNI Analysis Team Members: Kewei Chen, Ph.D., Eric M. Reiman, M.D. Gene E. Alexander, Ph.D. with issues in mind such as the correction of multiple comparisons. (5), data subject to change due to addition/change of subjects, time points and/or analysis type. (6), some brain regions, reported in AD neuroimaging literature, are included in the table w/o numeric data.(7), the field name consists of two parts: part 1 (the character string, maximum of 8 characters) is the brain region, and part 2 (the two digits at the very end) are index indicating analysis types. Variable Suffix 08 corresponds to AD CMRgl decline compared to that of normal controls over a 12 month period.","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","TMPMIDR08","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Temporal_Mid_R","","","N","8","6",">0","","","Normalized Counts","NA","same asCuneusL08","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","TMPINFL09","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Temporal_Inf_L","","","N","8","6",">0","","","Normalized Counts","NA","(1). Included baseline/12 month FDG-PET scan pairs for MCI patients. Within group baseline vs. 12-month follow-up paired T-test design (factors such as age, gender, apoe4 etc. are not considered in the analysis).? (2) local maxima extracted by examining CMRgl decline in MCI patients from baseline to followup. (3) (internal note) analysis on linux? /analysis/ADNI/quals/analysis/Bmin12m_Feb08 (4) SPM analyses were performed by ADNI Analysis Team Members: Kewei Chen, Ph.D., Eric M. Reiman, M.D. Gene E. Alexander, Ph.D. with issues in mind such as the correction of multiple comparisons. (5), data subject to change due to addition/change of subjects, time points and/or analysis type. (6), some brain regions, reported in AD/MCI neuroimaging literature, are included in the table w/o numeric data.(7), the field name consists of two parts: part 1 (the character string, maximum of 8 characters) is the brain region, and part 2 (the two digits at the very end) are index indicating analysis types. Variable Suffix 09 corresponds to MCI CMRgl decline over 12 month period","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","CINGPST09","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Cingulum_Post","","","N","8","6",">0","","","Normalized Counts","NA","same as TmpInfL09","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","PRECUNL09","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Precuneus_L","","","N","8","6",">0","","","Normalized Counts","NA","same as TmpInfL09","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","PARIINFR09","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Parietal_Inf_R","","","N","8","6",">0","","","Normalized Counts","NA","same as TmpInfL09","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","TMPINFL10","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Temporal_Inf_L","","","N","8","6",">0","","","Normalized Counts","NA","(1). Included baseline/12 month FDG-PET scan pairs, repeated ANOVA? design (factors such as age, gender, apoe4 etc. are not considered in the analysis).? (2) local maxima extracted by examining faster CMRgl decline in MCI patients than in controls (AD data included as well). (3) (internal note) analysis on linux? /analysis/ADNI/quals/analysis/long_021308/ANOVA_bslm12. (4) SPM analyses were performed by ADNI Analysis Team Members: Kewei Chen, Ph.D., Eric M. Reiman, M.D. Gene E. Alexander, Ph.D. with issues in mind such as the correction of multiple comparisons. (5), data subject to change due to addition/change of subjects, time points and/or analysis type. (6), some brain regions, reported in AD/MCI neuroimaging literature, are included in the table w/o numeric data. (7), the field name consists of two parts: part 1 (the character string, maximum of 8 characters) is the brain region, and part 2 (the two digits at the very end) are index indicating analysis types. Variable Suffix 10 corresponds to MCI CMRgl decline compared to that of normal controls over a 12 month period.","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","PRECUNL10","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Precuneus_L","","","N","8","6",">0","","","Normalized Counts","NA","same as TmpInfL10","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","TMPINFL11","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Temporal_Inf_L","","","N","8","6",">0","","","Normalized Counts","NA","(1). Included baseline/18 month FDG-PET scan pairs for MCI patients. Within group baseline vs. 18-month follow-up paired T-test design (factors such as age, gender, apoe4 etc. are not considered in the analysis).? (2) local maxima extracted by examining CMRgl decline in MCI patients from baseline to followup. (3) (internal note) analysis on linux? /san2/analysis/ADNI/quals/analysis/long_021308/ImgSubtract_MCI_bslm18 (4) SPM analyses were performed by ADNI Analysis Team Members: Kewei Chen, Ph.D., Eric M. Reiman, M.D. Gene E. Alexander, Ph.D. with issues in mind such as the correction of multiple comparisons. (5), data subject to change due to addition/change of subjects, time points and/or analysis type. (6), some brain regions, reported in AD/MCI neuroimaging literature, are included in the table w/o numeric data.(7), the field name consists of two parts: part 1 (the character string, maximum of 8 characters) is the brain region, and part 2 (the two digits at the very end) are index indicating analysis types. Variable Suffix 11 corresponds to MCI CMRgl decline over 18 month period","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","OCCMIDL11","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Occipital_Mid_L","","","N","8","6",">0","","","Normalized Counts","NA","same as TmpInfL11","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","CINGPST11","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Cingulum_Post_L","","","N","8","6",">0","","","Normalized Counts","NA","same as TmpInfL11","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","CINGMID11","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Cingulum_Post_R/Cingulum_Mid_R","","","N","8","6",">0","","","Normalized Counts","NA","same as TmpInfL11","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","TMPPOSR12","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Temporal_Pole_Sup_R","","","N","8","6",">0","","","Normalized Counts","NA","(1). Included baseline/12 month FDG-PET scan pairs for AD patients. Within group baseline vs. 12-month follow-up paired T-test design (factors such as age, gender, apoe4 etc. are not considered in the analysis), data from HRRT/biograph scanner excluded.? (2) local maxima extracted by examining CMRgl decline in AD patients from baseline to 12 mfollowup. (3) (internal note) analysis on linux? /san2/analysis/ADNI/quals/analysis/Bmin12m_Feb08_NPS/presMask000005_AD (4) SPM analyses were performed by ADNI Analysis Team Members: Kewei Chen, Ph.D., Eric M. Reiman, M.D. Gene E. Alexander, Ph.D. with issues in mind such as the correction of multiple comparisons. (5), data subject to change due to addition/change of subjects, time points and/or analysis type. (6), some brain regions, reported in AD/MCI neuroimaging literature, are included in the table w/o numeric data.(7), the field name consists of two parts: part 1 (the character string, maximum of 8 characters) is the brain region, and part 2 (the two digits at the very end) are index indicating analysis types. Variable Suffix 12 corresponds to AD CMRgl decline over 12 month period relative to the preserved/spared brain region","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","CINGPSTR12","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Cingulum_Post_R/Cingulum_Mid_R","","","N","8","6",">0","","","Normalized Counts","NA","(1). Included baseline/12 month FDG-PET scan pairs for AD patients. Within group baseline vs. 12-month follow-up paired T-test design (factors such as age, gender, apoe4 etc. are not considered in the analysis), data from HRRT/biograph scanner excluded.? (2) local maxima extracted by examining CMRgl decline in AD patients from baseline to 12 mfollowup. (3) (internal note) analysis on linux? /san2/analysis/ADNI/quals/analysis/Bmin12m_Feb08_NPS/presMask000005_AD (4) SPM analyses were performed by ADNI Analysis Team Members: Kewei Chen, Ph.D., Eric M. Reiman, M.D. Gene E. Alexander, Ph.D. with issues in mind such as the correction of multiple comparisons. (5), data subject to change due to addition/change of subjects, time points and/or analysis type. (6), some brain regions, reported in AD/MCI neuroimaging literature, are included in the table w/o numeric data.(7), the field name consists of two parts: part 1 (the character string, maximum of 8 characters) is the brain region, and part 2 (the two digits at the very end) are index indicating analysis types. Variable Suffix 12 corresponds to AD CMRgl decline over 12 month period relative to the preserved/spared brain region","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","FROITRN001","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Training group, all subjects","","","N","8","6",">0","","","Normalized Counts","NA","(1). Included baseline and month 12 FDG-PET scans, paired t-test (factors such as age, gender, apoe4 etc. are not considered in the analysis) with somatosensory (AAL 57/58) as reference region within each of the 3 diagnosis groups (AD/MCI/NL).?? (2) Extracted by examining the functionally defined ROI with 100% reliability as established with Bootstrap resampling procedure, decline of CMRgl in AD, MCI and NL separately. This training set was used to select the best reference region from automated anatomically labeled somatosensory (AAL post-central gyrus regions 57-58), motor (AAL precentral gyrus regions 1-2) and thalamic (AAL regions 77-78), pontine (using data generated from Dr. Foster??s lab) regions-of-interest (ROI), a cerebella ROI (using the cerebella ROI defined by Dr. Mony Deleon??s group) and using whole brain (using SPM), and a functionally preserved brain regions (in the 12-month analysis for each group, typically including sensorimotor cortex, and using different p-value thresholds to characterize the functionally defined ROI). (3) Data extracted for power analysis is ","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","FROITRN002","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Training group, exclude HRRT and BioGraph HiRez","","","N","8","6",">0","","","Normalized Counts","NA","(1). Included baseline and month 12 FDG-PET scans after excluding scans with QA/acquisition concerns, paired t-test (factors such as age, gender, apoe4 etc. are not considered in the analysis) with somatosensory (AAL 57/58) as reference region within each of the 3 diagnosis groups (AD/MCI/NL).?? (2) extracted by examining the functionally defined ROI with 100% reliability as established with Bootstrap resampling procedure, decline of CMRgl in AD, MCI and NL separately. This training set was used to select the best reference region from automated anatomically labeled somatosensory (AAL post-central gyrus regions 57-58), motor (AAL precentral gyrus regions 1-2) and thalamic (AAL regions 77-78), pontine (using data generated from Dr. Foster??s lab) regions-of-interest (ROI), a cerebella ROI (using the cerebella ROI defined by Dr. Mony Deleon??s group) and using whole brain (using SPM), and a functionally preserved brain regions (in the 12-month analysis for each group, typically including sensorimotor cortex, and using different p-value thresholds to characterize the functionally defined ROI). (3) Data extracted for power analysis is free of multiple comparisons (especially based the ","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","FROITST001","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Testing group, all scans","","","N","8","6",">0","","","Normalized Counts","NA","(1). Included baseline and month 12 FDG-PET scans, paired t-test (factors such as age, gender, apoe4 etc. are not considered in the analysis) with somatosensory (AAL 57/58) as reference region within each of the 3 diagnosis groups (AD/MCI/NL).?? (2) extracted by examining the functionally defined ROI with 100% reliability as established with Bootstrap resampling procedure, decline of CMRgl in AD, MCI and NL separately. This data was extracted after using the training set [see notes for fROItrn001 and for fROItrn002] to select the best reference region from automated anatomically labeled somatosensory (AAL post-central gyrus regions 57-58), motor (AAL precentral gyrus regions 1-2) and thalamic (AAL regions 77-78), pontine (using data generated from Dr. Foster??s lab) regions-of-interest (ROI), a cerebella ROI (using the cerebella ROI defined by Dr. Mony Deleon??s group) and using whole brain (using SPM), and a functionally preserved brain regions (in the 12-month analysis for each group, typically including sensorimotor cortex, and using different p-value thresholds to char","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","FROITST002","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Testing group, exclude HRRT and BioGraph HiRez","","","N","8","6",">0","","","Normalized Counts","NA","(1). Included baseline and month 12 FDG-PET scans after excluding scans with QA/acquisition concerns, paired t-test (factors such as age, gender, apoe4 etc. are not considered in the analysis) with somatosensory (AAL 57/58) as reference region within each of the 3 diagnosis groups (AD/MCI/NL).?? (2) extracted by examining the functionally defined ROI with 100% reliability as established with Bootstrap resampling procedure, decline of CMRgl in AD, MCI and NL separately. This data was extracted after using the training set [see notes for fROItrn001 and for fROItrn002] to select the best reference region from automated anatomically labeled somatosensory (AAL post-central gyrus regions 57-58), motor (AAL precentral gyrus regions 1-2) and thalamic (AAL regions 77-78), pontine (using data generated from Dr. Foster??s lab) regions-of-interest (ROI), a cerebella ROI (using the cerebella ROI defined by Dr. Mony Deleon??s group) and using whole brain (using SPM), and a functionally preserved brain regions (in the 12-month analysis for each group, typically including sensorimotor cortex, and using different p-value thresholds to characterize the functionally defined ROI). (3) Data ex","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","FROIWHL001","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","All subjects","","","N","8","6",">0","","","Normalized Counts","NA","(1). Included baseline and month 12 FDG-PET scans, paired t-test (factors such as age, gender, apoe4 etc. are not considered in the analysis) with somatosensory (AAL 57/58) as reference region within each of the 3 diagnosis groups (AD/MCI/NL).?? (2) extracted by examining the functionally defined ROI with 100% reliability as established with Bootstrap resampling procedure, decline of CMRgl in AD, MCI and NL separately. This data was extracted from ALL subjects (not divided as training and testing sub-sets) but after using the training set [see notes for fROItrn001 and for fROItrn002] to select the best reference region from automated anatomically labeled somatosensory (AAL post-central gyrus regions 57-58), motor (AAL precentral gyrus regions 1-2) and thalamic (AAL regions 77-78), pontine (using data generated from Dr. Foster??s lab) regions-of-interest (ROI), a cerebella ROI (using the cerebella ROI defined by Dr. Mony Deleon??s group) and using whole brain (using SPM), and a functionally preserved brain regions (in the 12-month analysis for each group, typically including sensorimotor cortex, and using different p-value thresholds to characterize the functionally defined ROI). (3) Data extracted for power analysis ","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","FROIWHL002","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Exclude HRRT and BioGraph HiRez","","","N","8","6",">0","","","Normalized Counts","NA","(1). Included baseline and month 12 FDG-PET scans after excluding scans with QA/acquisition concerns, paired t-test (factors such as age, gender, apoe4 etc. are not considered in the analysis) with somatosensory (AAL 57/58) as reference region within each of the 3 diagnosis groups (AD/MCI/NL).?? (2) extracted by examining the functionally defined ROI with 100% reliability as established with Bootstrap resampling procedure, decline of CMRgl in AD, MCI and NL separately. This data was extracted from ALL subjects (not divided as training and testing sub-sets) but after using the training set [see notes for fROItrn001 and for fROItrn002] to select the best reference region from automated anatomically labeled somatosensory (AAL post-central gyrus regions 57-58), motor (AAL precentral gyrus regions 1-2) and thalamic (AAL regions 77-78), pontine (using data generated from Dr. Fosters lab) regions-of-interest (ROI), a cerebella ROI (using the cerebella ROI defined by Dr. Mony Deleons group) and using whole brain (using SPM), and a functionally preserved brain regions (in the 12-month analysis for each group, typically including sensorimotor cortex, and using different p-value thresholds to characterize the functionally defined ROI). (3) Data extracted for power analysis is free of multiple comparisons (but not with train","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","FRPMSK001","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Exclude HRRT and BioGraph HiRez","","","N","8","6",">0","","","Normalized Counts","NA","(1) Analyses were performed using baseline, month 06 and month 12 FDG-PET scans for subjects identified by ADNI statistical core, excluding scans acquired on the HRRT and HiRes scanners. For each subject, the 3 time point data were fitted, voxel-by-voxel, to a straight line assuming the CMRgl decline over time is LINEAR. Real scan times, unit of year and baseline assumed to be time 0, were used for each subject.  For each subject, the estimated slope, the rate of change (annually), formed the beta image which was the input for the subsequent group analysis. In computing the beta image, the reference region used for each individual subject was the functionally defined brain regions spared (preserved) of the CMRgl decline, defined in a group analysis with the whole brain as the reference region for AD, MCI and NL separately. In the subsequent group analysis, factors such as age, gender, apoe4 etc. are not considered.    (2) for each subject, beta values were extracted and averaged over the previously  defined functional ROI ( fROI, reflecting consistent CMRgl declines) as established with Bootstrap resampling procedure, for AD, MCI and NL separately. These data were extracted from ALL subjects excluding those from the HRRT and HiRes scanners, which we originally found to be problematic before any of the follow-up scans were acquired, and not divided into training and testing sub-sets as we had done in the previous ADNI analysis).  In addition to characterizing a predefined, spatially distributed fROI mask for the assessment of CMRgl decline in the AD, MCI, and NL  groups using the original training set acquired on non-problematic scanners [see notes for fROItrn001 and for fROItrn002] , we selected the best reference  (i.e., spared) region from automated anatomically labeled somatosensory (AAL post-central gyrus regions 57-58), motor (AAL precentral gyrus regions 1-2) and thalamic (AAL regions 77-78), pontine (using data generated from Dr. Fosters lab) regions-of-interest (ROI), a cerebellar  ROI (using the cerebella ROI defined by Dr. Mony Deleons group) and using whole brain (using SPM), and a functionally preserved brain regions (in the 12-month analysis for each group, typically including  somatosensory cortex, and using different p-value thresholds to characterize the functionally defined ROI).  (3) Data extracted for  this power analysis is free of multiple comparison concerns--but please note that the entire dataset includes some subjects from the original training group  used to determine our functional and reference ROIs.  Internal Notes: (4) SPM analyses were performed by ADNI SPM Analysis Team Members: Kewei Chen, Ph.D., Eric M. Reiman, M.D. Gene E. Alexander, Ph.D.  (5) These data should be considered preliminary, since we continue to refine our reference ROI using the original training set, and we expect additional subjects, time-points, and other changes in the future.  (6) Some brain regions, reported in AD neuroimaging literature, are included in the table w/o numeric data.  (7) The field name consists of two parts: part 1 (the character string, maximum of 8 characters), fR, indicates data are extracted from functionally defined ROI; ??pMSK?? for fROI was based on previously defined mask. and part 2 (the three digits at the very end) are index indicating","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","FRPMSK002","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","All subjects","","","N","8","6",">0","","","Normalized Counts","NA","(1) Analyses were performed using baseline, month 06 and month 12 FDG-PET scans for ALL subjects identified by ADNI statistical core. For each subject, the 3 time point data were fitted, voxel-by-voxel, to a straight line assuming the CMRgl decline over time is LINEAR. Real scan times, unit of year and baseline assumed to be time 0, were used for each subject.  For each subject, the estimated slope, the rate of change (annually), formed the beta image which was the input for the subsequent group analysis. In computing the beta image, the reference region used for each individual subject was the functionally defined brain regions spared (preserved) of the CMRgl decline, defined in a group analysis with the whole brain as the reference region for AD, MCI and NL separately. In the subsequent group analysis, factors such as age, gender, apoe4 etc. are not considered.    (2) for each subject, beta values were extracted and averaged over the previously  defined functional ROI ( fROI, reflecting consistent CMRgl declines) as established with Bootstrap resampling procedure, for AD, MCI and NL separately. These data were extracted from ALL subjects, and not divided into training and testing sub-sets as we had done in the previous ADNI analysis).  In addition to characterizing a predefined, spatially distributed fROI mask for the assessment of CMRgl decline in the AD, MCI, and NL  groups using the original training set acquired on non-problematic scanners [see notes for fROItrn001 and for fROItrn002] , we selected the best reference  (i.e., spared) region from automated anatomically labeled somatosensory (AAL post-central gyrus regions 57-58), motor (AAL precentral gyrus regions 1-2) and thalamic (AAL regions 77-78), pontine (using data generated from Dr. Fosters lab) regions-of-interest (ROI), a cerebellar  ROI (using the cerebella ROI defined by Dr. Mony Deleons group) and using whole brain (using SPM), and a functionally preserved brain regions (in the 12-month analysis for each group, typically including  somatosensory cortex, and using different p-value thresholds to characterize the functionally defined ROI).  (3) Data extracted for  this power analysis is free of multiple comparison concerns--but please note that the entire dataset includes some subjects from the original training group  used to determine our functional and reference ROIs.  Internal Notes: (4) SPM analyses were performed by ADNI SPM Analysis Team Members: Kewei Chen, Ph.D., Eric M. Reiman, M.D. Gene E. Alexander, Ph.D.  (5) These data should be considered preliminary, since we continue to refine our reference ROI using the original training set, and we expect additional subjects, time-points, and other changes in the future.  (6) Some brain regions, reported in AD neuroimaging literature, are included in the table w/o numeric data.  (7) The field name consists of two parts: part 1 (the character string, maximum of 8 ch","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","FRTMSK003","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Exclude HRRT and BioGraph HiRez","","","N","8","6",">0","","","Normalized Counts","NA","(1) Analyses were performed using baseline, month 06 and month 12 FDG-PET scans for subjects identified by ADNI statistical core, excluding scans acquired on the HRRT and HiRez scanners. For each subject, the 3 time point data were fitted, voxel-by-voxel, to a straight line assuming the CMRgl decline over time is LINEAR. Real scan times, unit of year and baseline assumed to be time 0, were used for each subject.  For each subject, the estimated slope, the rate of change (annually), formed the beta image which was the input for the subsequent group analysis. In computing the beta image, the reference region used for each individual subject was the functionally defined brain regions spared (preserved) of the CMRgl decline, defined in a group analysis with the whole brain as the reference region for AD, MCI and NL separately. In the subsequent group analysis, factors such as age, gender, apoe4 etc. are not considered.    (2) subjects are divided into two groups training/testing. The training dataset was then used to examine the optimal setting combination (p-threshold used to define the spare region, smoothness applied to the image, and the p-values used to define the decline region, etc.) the settings determined in the training set and with the consideration of the robustness of the power estimate was used to generate the decline functional region of interest (fROI). This fROI is then directly applied to the testing dataset for final power estimate.  for each subject, beta values were extracted and averaged over the  defined functional ROI ( fROI, reflecting consistent CMRgl declines) for AD and  MCI separately. For  NL, the fROI for AD was ued for data extraction (data extracted using fROI for MCI was also performed but not included in this round of uploading). These data were extracted from ALL subjects excluding those from the HRRT and HiRez scanners, which we originally found to be problematic before any of the follow-up scans were acquired).  We selected the best reference  (i.e., spared) region from automated anatomically labeled somatosensory (AAL post-central gyrus regions 57-58), motor (AAL precentral gyrus regions 1-2) and thalamic (AAL regions 77-78), pontine (using data generated from Dr. Foster??s lab) regions-of-interest (ROI), a cerebellar  ROI (using the cerebella ROI defined by Dr. Mony Deleon??s group) and using whole brain (using SPM), and a functionally preserved brain regions (in the 12-month analysis for each group, typically including  somatosensory cortex, and using different p-value thresholds to characterize the functionally defined ROI).  (3) Data extracted for  this power analysis is free of multiple comparison concerns.  Intern","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","FRTMSK004","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","All subjects","","","N","8","6",">0","","","Normalized Counts","NA","(1) Analyses were performed using baseline, month 06 and month 12 FDG-PET scans for subjects identified by ADNI statistical core. For each subject, the 3 time point data were fitted, voxel-by-voxel, to a straight line assuming the CMRgl decline over time is LINEAR. Real scan times, unit of year and baseline assumed to be time 0, were used for each subject.  For each subject, the estimated slope, the rate of change (annually), formed the beta image which was the input for the subsequent group analysis. In computing the beta image, the reference region used for each individual subject was the functionally defined brain regions spared (preserved) of the CMRgl decline, defined in a group analysis with the whole brain as the reference region for AD, MCI and NL separately. In the subsequent group analysis, factors such as age, gender, apoe4 etc. are not considered.    (2) subjects are divided into two groups training/testing. The training dataset was then used to examine the optimal setting combination (p-threshold used to define the spare region, smoothness applied to the image, and the p-values used to define the decline region, etc.) the settings determined in the training set and with the consideration of the robustness of the power estimate was used to generate the decline functional region of interest (fROI). This fROI is then directly applied to the testing dataset for final power estimate.  for each subject, beta values were extracted and averaged over the  defined functional ROI ( fROI, reflecting consistent CMRgl declines) for AD and  MCI separately. For  NL, the fROI for AD was ued for data extraction (data extracted using fROI for MCI was also performed but not included in this round of uploading). These data were extracted from ALL subjects.  We selected the best reference  (i.e., spared) region from automated anatomically labeled somatosensory (AAL post-central gyrus regions 57-58), motor (AAL precentral gyrus regions 1-2) and thalamic (AAL regions 77-78), pontine (using data generated from Dr. Fosters lab) regions-of-interest (ROI), a cerebellar  ROI (using the cerebella ROI defined by Dr. Mony Deleons group) and using whole brain (using SPM), and a functionally preserved brain regions (in the 12-month analysis for each group, typically including  somatosensory cortex, and using different p-value thresholds to characterize the functionally defined ROI).  (3) Data extracted for  this power analysis is free of multiple comparison concerns.  Internal Notes: (4) SPM analyses were performed by ADNI SPM Analysis Team Members: Kewei Chen, Ph.D., Eric M. Reiman, M.D. Gene E. Alexander, Ph.D.  (5) These data should be considered preliminary, since we continue to refine our reference ROI using the original training set, and we expect additional subjects, time-points, and other changes in the future.  (6) Some brain regions, reported in AD neuroimaging literature, are included in the table w/o numeric data.  (7) The field name consists of two parts: part 1 (the character string, maximum of 8 characters), fR, indicates data are extracted from functionally defined ROI; ??tMSK?? for fROI was based on mask defined on the training dataset. and part 2 (the three digits at the very end) are index indicating different analyses of the same type (potential repeat over time et","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","FRTMSK005","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","All subjects","","","N","8","6",">0","","","Normalized Counts","NA","(1) Analyses were performed using baseline and month 18 FDG-PET scans for ONLY MCI subjects identified by ADNI statistical core. difference images were formed between the baseline and the M18 scans, the reference region used for each individual subject beinng the functionally defined brain regions spared (preserved) of the CMRgl decline, defined in a group analysis with the whole brain as the reference region. In the subsequent group analysis, factors such as age, gender, apoe4 etc. are not considered.    (2) subjects are divided into two groups training/testing. The training dataset was then used to examine the optimal setting combination (p-threshold used to define the spare region, smoothness applied to the image, and the p-values used to define the decline region, etc.) the settings determined in the training set and with the consideration of the robustness of the power estimate was used to generate the decline functional region of interest (fROI). This fROI is then directly applied to the testing dataset for final power estimate.  These data were extracted from ALL subjects.  We selected the best reference  (i.e., spared) region from automated anatomically labeled somatosensory (AAL post-central gyrus regions 57-58), motor (AAL precentral gyrus regions 1-2) and thalamic (AAL regions 77-78), pontine (using data generated from Dr. Foster??s lab) regions-of-interest (ROI), a cerebellar  ROI (using the cerebella ROI defined by Dr. Mony Deleon??s group) and using whole brain (using SPM), and a functionally preserved brain regions (in the 12-month analysis for each group, typically including  somatosensory cortex, and using different p-value thresholds to characterize the functionally defined ROI).  (3) Data extracted for  this power analysis is free of multiple comparison concerns.  Internal Notes: (4) SPM analyses were performed by ADNI SPM Analysis Team Members: Kewei Chen, Ph.D., Eric M. Reiman, M.D. Gene E. Alexander, Ph.D. ","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","FRTMSK006","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","All subjects","","","N","8","6",">0","","","Normalized Counts","NA","(1) Analyses were performed using baseline and month 24 FDG-PET scans for AD, MCI and NC subjects identified by ADNI statistical core. difference images were formed between the baseline and the M18 scans, the reference region used for each individual subject beinng the functionally defined brain regions spared (preserved) of the CMRgl decline, defined in a group analysis with the whole brain as the reference region for AD and MCI separately (extracted NL used the spared region defined by AD group). In the subsequent group analysis, factors such as age, gender, apoe4 etc. are not considered.    (2) subjects are divided into two groups training/testing. The training dataset was then used to examine the optimal setting combination (p-threshold used to define the spare region, smoothness applied to the image, and the p-values used to define the decline region, etc.) the settings determined in the training set and with the consideration of the robustness of the power estimate was used to generate the decline functional region of interest (fROI). This fROI is then directly applied to the testing dataset for final power estimate.  These data were extracted from ALL subjects.  We selected the best reference  (i.e., spared) region from automated anatomically labeled somatosensory (AAL post-central gyrus regions 57-58), motor (AAL precentral gyrus regions 1-2) and thalamic (AAL regions 77-78), pontine (using data generated from Dr. Foster??s lab) regions-of-interest (ROI), a cerebellar  ROI (using the cerebella ROI defined by Dr. Mony Deleon??s group) and using whole brain (using SPM), and a functionally preserved brain regions (in the 12-month analysis for each group, typically including  somatosensory cortex, and using different p-value thresholds to characterize the functionally defined ROI).  (3) Data extracted for  this power analysis is free of multiple comparison concerns.  Internal Notes: (4) SPM analyses were performed by ADNI SPM Analysis Team Members: Kewei Chen, Ph.D., Eric M. Reiman, M.D. Gene E. Alexander, Ph.D.  (5) These data should be considered preliminary, since we continue to refine our referenc","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","FRTMSK007","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","All subjects","","","N","8","6",">0","","","Normalized Counts","NA","(1) Same as fRtMsk005 but with data from additional subjects, analyses were performed using baseline and month 18 FDG-PET scans for ONLY MCI subjects identified by ADNI statistical core. difference images were formed between the baseline and the M18 scans, the reference region used for each individual subject beinng the functionally defined brain regions spared (preserved) of the CMRgl decline, defined in a group analysis with the whole brain as the reference region. In the subsequent group analysis, factors such as age, gender, apoe4 etc. are not considered.    (2) subjects are divided into two groups training/testing. The training dataset was then used to examine the optimal setting combination (p-threshold used to define the spare region, smoothness applied to the image, and the p-values used to define the decline region, etc.) the settings determined in the training set and with the consideration of the robustness of the power estimate was used to generate the decline functional region of interest (fROI). This fROI is then directly applied to the testing dataset for final power estimate.  These data were extracted from ALL subjects.  We selected the best reference  (i.e., spared) region from automated anatomically labeled somatosensory (AAL post-central gyrus regions 57-58), motor (AAL precentral gyrus regions 1-2) and thalamic (AAL regions 77-78), pontine (using data generated from Dr. Foster??s lab) regions-of-interest (ROI), a cerebellar  ROI (using the cerebella ROI defined by Dr. Mony Deleon??s group) and using whole brain (using SPM), and a functionally preserved brain regions (in the 18-month analysis for each group, typically including  somatosensory cortex, and using different p-value thresholds to characterize the functionally defined ROI).  (3) Data extracted for  this power analysis is free of multiple comparison concerns.  Internal Notes: (4) SPM analyses were performed by ADNI SPM Analysis Team Members: Kewei Chen, Ph.D., Eric M. Reiman, M.D. Gene E. Alexander, Ph.D.  (5) These data should be considered preliminary, since we","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","FRTMSK008","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Exclude HRRT and BioGraph HiRez","","","N","8","6",">0","","","Normalized Counts","NA","(1) As fRtMsk007 excluding HRRT and HiRez scan data, and  with data from additional subjects, analyses were performed using baseline and month 18 FDG-PET scans for ONLY MCI subjects identified by ADNI statistical core. difference images were formed between the baseline and the M18 scans, the reference region used for each individual subject beinng the functionally defined brain regions spared (preserved) of the CMRgl decline, defined in a group analysis with the whole brain as the reference region. In the subsequent group analysis, factors such as age, gender, apoe4 etc. are not considered.    (2) subjects are divided into two groups training/testing. The training dataset was then used to examine the optimal setting combination (p-threshold used to define the spare region, smoothness applied to the image, and the p-values used to define the decline region, etc.) the settings determined in the training set and with the consideration of the robustness of the power estimate was used to generate the decline functional region of interest (fROI). This fROI is then directly applied to the testing dataset for final power estimate.  These data were extracted from ALL subjects.  We selected the best reference  (i.e., spared) region from automated anatomically labeled somatosensory (AAL post-central gyrus regions 57-58), motor (AAL precentral gyrus regions 1-2) and thalamic (AAL regions 77-78), pontine (using data generated from Dr. Foster??s lab) regions-of-interest (ROI), a cerebellar  ROI (using the cerebella ROI defined by Dr. Mony Deleon??s group) and using whole brain (using SPM), and a functionally preserved brain regions (in the 18-month analysis for each group, typically including  somatosensory cortex, and using different p-value thresholds to characterize the functionally defined ROI).  (3) Data extracted for  this power analysis is free of multiple comparison concerns.  Internal Notes: (4) SPM analyses were performed by ADNI SPM Analysis Team Members: Kewei Chen, Ph.D., Eric M. Reiman, M.D. Gene E. Alexander, Ph.D.  (5) These data should be considered preliminary, since we continue to refine our referenc","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","FRTMSK009","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","All subjects","","","N","8","6",">0","","","Normalized Counts","NA","(1) Same as fRtMsk006 but with data from additonal subjects, analyses were performed using baseline and month 24 FDG-PET scans for AD, MCI and NC subjects identified by ADNI statistical core. difference images were formed between the baseline and the M24 scans, the reference region used for each individual subject beinng the functionally defined brain regions spared (preserved) of the CMRgl decline, defined in a group analysis with the whole brain as the reference region for AD and MCI separately (extracted NL used the spared region defined by AD group). In the subsequent group analysis, factors such as age, gender, apoe4 etc. are not considered.    (2) subjects are divided into two groups training/testing. The training dataset was then used to examine the optimal setting combination (p-threshold used to define the spare region, smoothness applied to the image, and the p-values used to define the decline region, etc.) the settings determined in the training set and with the consideration of the robustness of the power estimate was used to generate the decline functional region of interest (fROI). This fROI is then directly applied to the testing dataset for final power estimate.  These data were extracted from ALL subjects.  We selected the best reference  (i.e., spared) region from automated anatomically labeled somatosensory (AAL post-central gyrus regions 57-58), motor (AAL precentral gyrus regions 1-2) and thalamic (AAL regions 77-78), pontine (using data generated from Dr. Foster??s lab) regions-of-interest (ROI), a cerebellar  ROI (using the cerebella ROI defined by Dr. Mony Deleon??s group) and using whole brain (using SPM), and a functionally preserved brain regions (in the 24-month analysis for each group, typically including  somatosensory cortex, and using different p-value thresholds to characterize the functionally defined ROI).  (3) Data extracted for  this power analysis is free of multiple comparison concerns.  Internal Notes: (4) SPM analyses were performed by ADNI SPM Analysis Team Members: Kewei Chen, Ph.D., Eric M. Reiman, M.D. Gene E. Alexander, Ph.D.  (5) These data should be considered preliminary, since we continue to refine our reference ROI using the original training set, and we expect addi","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","FRTMSK010","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Exclude HRRT and BioGraph HiRez","","","N","8","6",">0","","","Normalized Counts","NA","(1) Same as fRtMsk009 but excluding subjects whose scans were frmo HRRT and hiRez, and also with data from additonal subjects, analyses were performed using baseline and month 24 FDG-PET scans for AD, MCI and NC subjects identified by ADNI statistical core. difference images were formed between the baseline and the M24 scans, the reference region used for each individual subject beinng the functionally defined brain regions spared (preserved) of the CMRgl decline, defined in a group analysis with the whole brain as the reference region for AD and MCI separately (extracted NL used the spared region defined by AD group). In the subsequent group analysis, factors such as age, gender, apoe4 etc. are not considered.    (2) subjects are divided into two groups training/testing. The training dataset was then used to examine the optimal setting combination (p-threshold used to define the spare region, smoothness applied to the image, and the p-values used to define the decline region, etc.) the settings determined in the training set and with the consideration of the robustness of the power estimate was used to generate the decline functional region of interest (fROI). This fROI is then directly applied to the testing dataset for final power estimate.  These data were extracted from ALL subjects (but excluding those from HRRT and hiRez scanners).  We selected the best reference  (i.e., spared) region from automated anatomically labeled somatosensory (AAL post-central gyrus regions 57-58), motor (AAL precentral gyrus regions 1-2) and thalamic (AAL regions 77-78), pontine (using data generated from Dr. Foster??s lab) regions-of-interest (ROI), a cerebellar  ROI (using the cerebella ROI defined by Dr. Mony Deleon??s group) and using whole brain (using SPM), and a functionally preserved brain regions (in the 24-month analysis for each group, typically including  somatosensory cortex, and using different p-value thresholds to characterize the functionally defined ROI).  (3) Data extracted for  this power analysis is free of multiple comparison concerns.  Internal Notes: (4) SPM analyses were performed by ADNI SPM Analysis Team Members: Kewei Chen, Ph.D., Eric M. Reiman, M.D. Gene E. Alexander, Ph.D.  (5) These data should be considered preliminary, since we continue to refine our reference ROI using the original training set, and we expect additional subjects, time-points, and other changes in the future.  (6) Some brain regions, reported in AD neuroimaging l","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","FRTMSK011","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","All subjects","","","N","8","6",">0","","","Normalized Counts","NA","(1) Analyses were performed using baseline and month 36 FDG-PET scans for ONLY MCI subjects identified by ADNI statistical core. difference images were formed between the baseline and the M36 scans, the reference region used for each individual subject beinng the functionally defined brain regions spared (preserved) of the CMRgl decline, defined in a group analysis with the whole brain as the reference region. In the subsequent group analysis, factors such as age, gender, apoe4 etc. are not considered.    (2) subjects are NOT divided into two groups training/testing since the number of subjects is limited for such a practice. We continued the practice of using the spared region, the same smoothness, and the p-values used to define the decline region, etc.). The power estimate was done this round w/o the trainning testing cross-validation.  These data were extracted from ALL subjects.   (3) Data extracted for  this power analysis is free of multiple comparison concerns.  Internal Notes: (4) SPM analyses were performed by ADNI SPM Analysis Team Members: Kewei Chen, Ph.D., Eric M. Reiman, M.D. Gene E. Alexander, Ph.D.  (5) These data should be considered preliminary, since we need to define our reference ROI using a training set with a relatively large N, and we expect additional subjects, time-points, and other changes in the future.  (6) Some brain regions, reported in AD neuroimaging literature, are included in the table w/o numeric data.  (7) The field name consists of two parts: part 1 (the character string, maximum of 8 characters), fR, indicates data are extracted from functionally defined ROI; ??tMSK?? for fROI was based on mask defined on the training dataset. and part 2 (the three digits at the very end) are index indicating different analyses of the same type (potential repeat over time etc.).","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","IPCA","BAINMRC","Banner Alzheimer's Institute NMRC Summaries",""," percent annualized whole brain atrophy detected by Iterative Principal component Analysis (IPCA) ","","","N","8","6","[-5,5]","","","Percentage","NA","(1) Included the whole brain atrophy results from baseline to 12 month MRI scan pairs for 167 normal controls, 288 MCI and 125 AD patients   (2) The whole brain atrophy was measured using IPCA independently for each subject, thus is not subject to change due to addition/removal of subjects. (3) In the subsequent group analysis, factors such as age, gender, apoe4 were not considered.    (4) Subjects were NOT divided into training/testing groups. The analysis was  for  subjects whose data were available at the time of the initiation and whose data passed the internal QA . (5) Whole brain atrophy detected by IPCA is a global index, thus is free of multiple comparison issue. (6) The numerical value for each subject is the atrophy rate from baseline to 12 month (though it was listed for the baseline row in the numerical sheet, it is a single measure for both baseline and 12 month). The IPCA measured whole brain atrophy we observed from analyzing multiple datasets is below 5% (hence the theoretical [-5 5] range, which is true for this dataset","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","HCISUB1","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","hypometabolic convergence index for 74 AD subjects","","","N","5","2",">0","","","unitless","NA","(1) Analyses were performed using baseline FDG-PET scans from 74 AD subjects.  (2) In this analysis the AD patients were subdivided into AD decline group and AD stable group by changes in MMSE score from Baseline to 12 months.  AD decline subjects were designated as patients that had a change in MMSE score from Baseline to 12 months greater than 2.5. Stable patients were designated by a change in MMSE score from Baseline to 12 months less than 2.5.  (3) The reference region used for each individual subject is the whole brain estimated by spm_global. In the subsequent group analysis, factors such as age, gender, apoe4 etc. are not considered.    (4) Subjects are NOT divided into training/testing group (and there is no such need).   (5) Hypometabolic convergence index (HCI) measures how strongly the pattern of cerebral hypometabolism in one individual subject corresponds to that in the AD group. It is a global single index which is free of multiple comparisons.  Significant difference was observed between the AD decline subjects and the AD stable subjects (no difference for baseline MMSE). (6) This set of the HCI scores were calculated based on SPM8, were for a smaller number of subjects. They were calcuatled separately and differently (some pre-processing setting changes etc.) but highly correlated with those in a separate set of HCI scores based on SPM8 for ALL subjects over multiple time points were calculated recently and being part of this round of data upload (see HCI variable).  (7) The analysis was performed prior to the FDG-PET QA/acquisition issues being fully addressed, description of the issues dated at 05/01/2009 (http://www.loni.ucla.edu/twiki/bin/view/ADNI/ADNIPETCore?skin=plain).  (8)  These data should be considered preliminary, since we continue to refine our HCI approach using the original training set and the data QA issue, and we expect additional subjects, time-points, and other changes in the future.  (9) HCIsub1, the field name consists of 2 parts: part 1- the type of analysis (HCI), and part 2-sub1 represents to the analysis is performed on a subset of subjects separately.","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","HCI99","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","hypometabolic convergence index for normal controls, stable MCI, MCI converter and ADs","","","N","5","2",">0","","","unitless","NA","(1) Analyses were performed using baseline FDG-PET scans from 47 normal controls 97 MCIs and 44 AD subjects.? (2) Also for  this analysis the MCI patients were subdivided by their conversion to AD following the baseline scan visits.? MCI converters were defined as MCI patients who later converted to AD within 18 months after baseline scan; those who did not were considered Stable MCIs. (3) The reference region used for each individual subject is the whole brain measurements (spm_global). In the subsequent group analysis, factors such as age, gender, apoe4 etc. are not considered.??? (4) Subjects are NOT divided into training/testing groups (and there is no such need).?? (5) Hypometabolic convergence index (HCI) measures how strongly the pattern of cerebral hypometabolism of one individual subject corresponds to that in the AD group. It is a global index, thus is free of multiple comparison issue. ?MCI subjects who had high HCI at baseline are significantly more likely to convert to AD within 18 months than those who had low HCI. (6) This set of the HCI scores were calculated based on SPM99, were for a smaller number of subjects. They were calculated separately and differently (using the older SPM99 version) but highly correlated with those in a separate set of HCI scores based on SPM8 for ALL subjects over multiple time points  that were calculated recently and being part of this round of data upload (see HCI variable).  (7) The analysis was performed prior to the FDG-PET QA/acquisition issues being fully addressed, description of the issues dated at 05/01/2009 (http://www.loni.ucla.edu/twiki/bin/view/ADNI/ADNIPETCore?skin=plain).  (8)  These data should be considered preliminary, since we continue to refine our HCI approach using the original training set and the data QA issue, and we expect additional subjects, time-points, and other changes in the future.  (9) HCI99, the field name consists of 2 parts: part 1- the type of analysis (HCI), and part 2-99 represents  the fact that the analysis was performed on SPM 99 on a subset of subjects separately.","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","HCI","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","hypometabolic convergence index for ADNI1 subjects","","","N","5","2",">0","","","unitless","NA","(1) Analyses were performed on ALL available ADNI1 subjects and ALL available time points (up to 60 months) FDG-PET scans.? (2) The reference region used for each individual subject is the whole brain measurement (spm_global). (3) Subjects are NOT divided into training/testing groups.?? (4) Hypometabolic convergence index (HCI) measures how strongly the pattern of cerebral hypometabolism of one individual subject corresponds to that in the AD group. It is a global index, thus is free of multiple comparison issue. Significant difference was observed between the AD, MCI, and Normal subjects at various time points and we also observed differential HCI increases over times among these 3 groups. (5) This set of the HCI scores were calculated based on SPM8.  (6) The analysis was performed prior to the FDG-PET QA/acquisition issues being fully addressed, description of the issues dated at 05/01/2009 (http://www.loni.ucla.edu/twiki/bin/view/ADNI/ADNIPETCore?skin=plain).  (7)  These data should be considered preliminary, since we continue to refine our HCI approach using the original training set and the data QA issue, and we expect additional subjects, time-points, and other changes in the future (from ADNI-GO and ADNI2 projects, e.g).  (8) HCI, the field name reflects the type of analysis (HCI).","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","NL1HIPP","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","difference of globally normalized CMRgl from Baseline to 12 months and 12 months to 24 months from Hippocampus for 58 AD patients","","","N","9","6","[-1,1]","","","Normalized Counts","NA","(1) For SPM voxel-wise analysis of  58 AD patients: Hippocampal CMRgl shows no significant decline from baseline to 12 month, but from 12month to 24 month (survived SVC). The rates of decline between yr 1 and yr 2 are different significantly at p=0.017 (but NS after SVC). (2) For the variable nl1Hipp in the numerical sheet file, 2010_12_31_bai_nmrc_data.csv, uploaded together with this document, the baseline row for each subject lists actually the global (spm_global) corrected difference between baseline and month 12. Similarly, the m12 row lists the same difference between month 12 and month 24. (3) In the subsequent group analysis, factors such as age, gender, apoe4 were not considered.    (4) Subjects were NOT divided into training/testing groups. (5) SPM analysis (group analysis and small volume correction (svc)) was performed in SPM5 to examine the within group rate of CMRgl decline from baseline to 12 month , and from 12 month to 24 month separately, and also to examine the decline rate difference over these two 1-year periods (different  rates implied CMRgl decline non-linearly, or piecewise linear in our case). We found a significant CMRgl decline rate differences between these two periods at p=0.017 (but NS after SVC). (6) The analysis was performed prior to the FDG-PET QA/acquisition issues being fully addressed, descriptio","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","NL1PTEMP","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","difference of globally normalized CMRgl from Baseline to 12 months and 12 months to 24 months from the parietotemporal region for 58 AD patients","","","N","9","6","[-1,1]","","","Normalized Counts","NA","(1) Similar as nl1Hipp, but for analysis of 58 AD patient in two other regions: parietotemporal and posterior cingulate, we observed no significant difference between yr1 and yr 2 CMRgl rate of decline. (2) For the variable nl1ptemp in the numerical sheet file, 2010_12_31_bai_nmrc_data.csv, uploaded together with this document, the baseline row for each subject lists actually the global corrected (by spm_global) difference between baseline and month 12. Similarly, the m12 row lists the same difference between month 12 and month 24. (3) In the subsequent group analysis, factors such as age, gender, apoe4 were not considered.    (4) Subjects were NOT divided into training/testing groups. (5) SPM analysis (group analysis and small volume correction (svc)) was performed in SPM5 to examine the within group rate of CMRgl decline from baseline to 12 month, and from 12 month to 24 month separately, and also to examine the decline rate difference over these two 1-year periods (different  rates implied CMRgl decline non-linearly, or piecewise linear in our case). We found no significant CMRgl decline rate differences between these two periods (null hypothesis: change from baseline to 24 month in linear fashion). (6) The analysis was performed prior to the FDG-PET QA/acquisition issues being","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","NL1PSTCG","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","difference of globally normalized CMRgl from Baseline to 12 months and 12 months to 24 months from the posterior cingulate for for 58 AD patients","","","N","9","6","[-1,1]","","","Normalized Counts","NA","same as nl1ptemp","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","NL2PSTCG","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","difference of globally normalized CMRgl from Baseline to 12 months and 12 months to 24 months from Posterior Cingulate in 129 MCIs.","","","N","9","6","[-1,1]","","","Normalized Counts","NA","(1) The globally corrected CMRglu difference in the first year and the second year were measured for the 129 MCI patients in posterior cingulate (2) For the variable nl2pstcg in the numerical sheet file, 2010_12_31_bai_nmrc_data.csv, uploaded together with this document, the baseline row for each subject lists actually the global corrected difference between baseline and month 12. Similarly, the m12 row lists the same difference between month 12 and month 24.  (3) In the subsequent group analysis, factors such as age, gender, apoe4 were not considered.    (4) Subjects were NOT divided into  training/testing groups. (5) SPM analysis was performed in SPM5  to examine the within group rate of CMRgl decline from baseline to 12 month, and from 12 month to 24 month separately, and also to examine the decline rate difference over these two 1-year periods (different  rates implied CMRgl decline non-linearly, or piecewise linear in our case). We found no significant CMRgl decline rate differences between these two periods (null hypothesis: change from baseline to 24 month ","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","NL2PARI","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","difference of globally normalized CMRgl from 12 months to 24 months from the inferior parietal region in 129 MCI subjects","","","N","9","6","[-1,1]","","","Normalized Counts","NA","(1) The globally corrected CMRglu difference in the second year was measured for the 129 MCI patients in inferior parietal region (2) For the variable nl2pari in the numerical sheet file, 2010_12_31_bai_nmrc_data.csv, uploaded together with this document, the m12  row for each subject lists actually the global corrected difference between month 12 and month 24. (3) In the subsequent group analysis, factors such as age, gender, apoe4 were not considered.    (4) Subjects were NOT divided into two groups training/testing. (5) SPM analysis was performed in SPM5  to examine the within group rate of CMRgl decline from baseline to 12 month , and from 12 month to 24 month separately, and also to examine the decline rate difference over these two 1-year periods (different  rates implied CMRgl decline non-linearity, or piecewise linear in our case). Although we did not see significant decline in this region in the first year and we do see significant decline in the second year, we found no significant CMRgl decline rate differences between these two periods (null hypothesis: change from baseline to 24 month in linear fashion). (6) The analysis was performed prior to the FDG-PET QA/acquisition issues being fully addressed, description of the issues dated at 05/01/2009. (http://www.loni.ucla.edu/twiki/bin/view/ADNI/ADNIPETCore?skin=plain).  (7) ?These data should be considered preliminary; we expect additional subjects, time-points, and other changes in the future.? (8) nl2pari, the field name, consists of 3 parts: part 1- nl refers to  what we are investigating(nonlinearity), and part 2- 2 refers to index for which group (MCI) we are looking at and part 3: and pari refers to the region of interest (inferior parietal).","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","NL3FRONT","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","difference of globally normalized CMRgl from Baseline to 12 months and 12 months to 24 months from superior frontal region of 74 normal controls.","","","N","9","6","[-1,1]","","","Normalized Counts","NA","(1) The globally corrected CMRglu difference in the first year and the second year were measured for the 74 normal controls (NC) subjects in superior medial frontal region (2) For the variable nl3frontin the numerical sheet file, 2010_12_31_bai_nmrc_data.csv, uploaded together with this document, the baseline row for each subject lists actually the global corrected difference between baseline and month 12. Similarly, the m12 row lists the same difference between month 12 and month 24. (3) In the subsequent group analysis, factors such as age, gender, apoe4 were not considered.    (4) Subjects were NOT divided into two groups training/testing. (5) SPM analysis was performed in SPM5  to examine the within group rate of CMRgl decline from baseline to 12 month , and from 12 month to 24 month separately, and also to examine the decline rate difference over these two 1-year periods (different  rates implied CMRgl decline non-linearly, or piecewise linear in our case). We found no significant CMRgl decline rate differences between these two periods (null hypothesis: change from baseline to 24 month in linear fashion).  (6) The ","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","DECLADFR","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","difference of globally normalized CMRgl from Baseline to 12 months from the superior frontal region of 74 AD patients","","","N","9","6","[-1,1]","","","Normalized Counts","NA","(1) Analyses were performed using baseline and 12 months FDG-PET scans from 74 AD subjects.? (2) For this analysis the AD patients were subdivided into AD decline subjects and AD stable subjects by a change in MMSE score from Baseline to 12 months.? AD decline subjects were designated as patients that had a decline in MMSE score from Baseline to 12 months greater than 2.5. Stable patients were designated by a change in MMSE score from Baseline to 12 months less than 2.5.?(3) For the variable declADfr in the numerical sheet file, 2010_12_31_bai_nmrc_data.csv, uploaded together with this document, the baseline row for each subject lists actually the global corrected difference between baseline and month 12. (4)  The reference region used for each individual subject is the whole brain (spm_global).   In the subsequent group analysis, factors such as age, gender, apoe4 etc. are not considered.??? (5) Subjects are NOT divided into training/testing groups.?? (6)?SPM analysis was performed in SPM5 to examine the within group rate of CMRgl decline from baseline to 12 month between decliners and stable group.  (7) The analysis was performed prior to the FDG-PET QA/acquisition issues being fully addressed, description of the issues dated at 05/01/2009 (http://www.loni.ucla.edu/twiki/bin/view/ADNI/ADNIPETCore?skin=plain).  (8) ?These data should be considered preliminary; we expect additional subjects, time-points, and other changes in the future.? (9) declADfr, the field name consists of 3 parts: part 1- decl represents that we are looking at differences between rapid decliners and a stable group  and part 2-AD represents the group we are looking further into, part 3- Fr is the region (frontal), we extracted CMRglu changes from baseline to 12 months.","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","DECLADTMP","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","CMRgl from Baseline from the inferior temporal region of 74 AD patients","","","N","8","6",">0","","","Normalized Counts","NA","(1) Analyses were performed using baseline FDG-PET scans from 74 AD subjects.? (2) For this analysis the AD patients were subdivided into AD decline subjects and AD stable subjects by a change in Mini Mental State Examination (MMSE) score from Baseline to 12 months.? AD decline subjects were designated as patients that had a decline in MMSE score from Baseline to 12 months greater than 2.5. Stable patients were designated by a change in MMSE score from Baseline to 12 months less than 2.5.? (3) The reference region used for each individual subject is the whole brain (spm_global).   In the subsequent group analysis, factors such as age, gender, apoe4 etc. are not considered.??? (4) Subjects are NOT divided into two groups training/testing.?? (5)?SPM analysis was performed in SPM5 to examine the CMRgl difference at baseline between decliners and stable group.  (6) The analysis was performed prior to the FDG-PET QA/acquisition issues being fully addressed, description of the issues dated at 05/01/2009 (http://www.loni.ucla.edu/twiki/bin/view/ADNI/ADNIPETCore?skin=plain).  (7) ?These data should be considered preliminary; we expect additional subjects, time-points, and other changes in the future.? (8) declADtmp, the field name consists of 3 parts: part 1- decl represents that we are looking at differences between rapid decliners and a stable group  and part 2-AD represents the group we are looking further into, part 3- tmp is the region (temporal ).","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","LONGHCI","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","Extension of HCI to longitudinal data","","","N","9","6","all real numbers","","","unitless","NA","Data is derived from brain, both hemispheres, gray and white matter only, from FDG PET scans","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"
"","BSLVBM","BAINMRC","Banner Alzheimer's Institute NMRC Summaries","","VBManalysis of structural MRI data","","","N","8","6","[0,1]","","","unitless","NA","Data is derived from brain, both hemispheres, gray matter volume from T1 MRI.","","","","","","","","","","","","","","","","2011-04-20 12:41:43.0"